Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Cann Group.
RELATED STOCKHEAD STORIES
Director Trades
Directors’ Trades: Otto Buttula buys another $580k of Rhythm Biosciences shares
Health & Biotech
Why haven’t any ASX pot stocks got CBD on Australian pharmacy shelves yet? And when will we see them?
Mining
ASX Pot Stocks: BOD Australia jumps 12% on record $7.52 million revenue for FY21
Guides
ASX Cannabis Stocks Guide 2021: Here’s everything you need to know
News
Closing Bell: ASX gains over 0.5pc to reach new record high
News
Pot Stocks: Emyria and Cann split, but who will win the race to register their CBD product first?
News
Weed Week: Cannabis ice cream deal and Israeli CBD market worth US$475m by 2025
News
Weed Week: Cannabis business degrees, cornering Germany’s €200M market and Hanks Kerchiefs hits stores
Health & Biotech
ASX health stocks: 4D Medical leads after ramping up its game in the US
News
As the Finance Forum drama entangles Westpac and Humm, here are some other ASX stocks in hot water
Health & Biotech
Weed Week: Major shifts in US legislation set to open the door for some ASX cannabis stocks
Health & Biotech
Phillip Morris mulls cannabis, pot market gets up off the couch… almost
Health & Biotech
Hot Pot Stocks: Here are 8 ASX plays that have tripled in the last 12 months
Health & Biotech
Cann Group, Emyria team up in bid to gain TGA approval for low-dose CBD gelcap
Health & Biotech
Not covered: Cann Group on the hook for $3.6 million cybersecurity incident
News
Last Orders: Stocks climb again as the ASX issues more speeding tickets
Health & Biotech
